Who we are

 Prevention Research Consortium Corp is a non-profit organization focused on reducing the global burden of dementia.  Our members include an interdisciplinary team of Genomics Experts, Proteomic Specialists, Neurologists, Psychiatrists, Primary Care Providers, Caregivers, Dementia Patients, Digital Technologists, Bioinformaticians,  AI Specialists, and Generalists.

Our Mission

  Develop and validate scalable biomarker tools for the early prediction and staging of mild cognitive impairment ( The precursor to All Cause Dementia) . We leverage proteomic, genomic, and AI-driven approaches to enable accurate, accessible early detection of  mixed pathology cases.

Building on this foundation, we aim to promote unbiased and independently validated technologies to improve detection and prevention of all diseases. Our goal is to help drive the shift from precision medicine to precision health—moving from reactive care to proactive, individualized prevention.

By  integrating  genomic, exposomic ( pollutants, diet + microbiome), metabolomic, proteomic, immunome, and RNA technologies into rigorous clinical research, we seek to deliver evidence-based strategies that improve outcomes, personalize care, and reduce the global burden of dementia and other diseases.

Our Approach

We evaluate the sensitivity and specificity of biomarker tools with a focus on early prediction or diagnosis of Late-Onset Alzheimer's Disease (LOAD). While our current efforts center on Alzheimer's, our General Proteogenomic and Exposome Approach is broadly applicable to advancing precision healthcare across a wide range of conditions.  Our LOAD Biology Model is being evaluated in a prospective  clinical study  to assess  tools  that predict and subclassify Mild Cognitive Impairment .   We plan to help evolve mathematical models and data collection tools to meet the challenges of predictive analytics.